CHRNA4 and tuberculosis: To determine if nAChR antagonists could be useful in shortening the duration of second-line chemotherapy, 60 days after mice were infected with an MDR TB strain, treatment with second-line antibiotics alone or in combination with MLA and DHβE was initiated.